Explore more publications!

The Middle East Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.

Press releases published on November 13, 2025

Green Tree Family Medicine Opens in West Palm Beach to Deliver Compassionate Primary Care
AppSecAI delivers proven results showcasing AI-powered remediation as OpenAI's Aardvark confirms AI's AppSec potential
M2MMA Reaffirms Its Policy Against Alcohol Sponsorships as Part of Its Commitment to Athlete Wellbeing
“LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in the United Kingdom
Allsup Helps Individuals Apply For SSDI Benefits After Longest Government Shutdown Ends
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2026
Aptose Reports Third Quarter 2025 Results
Eupraxia Pharmaceuticals Reports Additional 52-week Follow-up Data from the RESOLVE Trial in Eosinophilic Esophagitis (EoE) Demonstrating Consistent Results after Dosing with EP-104GI
SAB BIO Reports Third Quarter Financial Results and Recent Business Highlights
Precision Optics Reports First Quarter Fiscal Year 2026 Financial Results
Senti Bio Reports Third Quarter 2025 Financial Results and Confirms Next Clinical Data Readout for Phase 1 SENTI-202 Study in Acute Myeloid Leukemia (AML) at the American Society of Hematology Annual Meeting in December
NANOBIOTIX Announces Curadigm Nanoprimer Platform Advancements With Updated Plans for Internal Pipeline Development and External Collaborations
NANOBIOTIX annonce les avancées de sa plateforme de nanoprimer Curadigm avec une mise à jour des plans de développement pour son pipeline interne et des collaborations externes
Catheter Precision (VTAK) Reports Third Quarter and First Nine Months 2025 Results of Operations
Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights
Sienna Reports Third Quarter 2025 Financial Results and Continues Growth in Greater Toronto Area
Alumis Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
Nyxoah Reports Third Quarter 2025 Financial and Operating Results
Nyxoah Présente ses Résultats Financiers et d’Exploitation  pour le Troisième Trimestre 2025
ORIC® Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Clinical and Operational Updates

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions